Article metrics

Download PDFPDF

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2021

AbstractFullPdf
Nov 2020566075
Dec 202076010
Jan 202168011
Feb 202154010
Mar 202174017
Apr 202184016
May 202115017
Jun 20210013
Jul 20210032
Aug 20210019
Sep 20210013
Total9370233